Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.

Lee YH, Lee HS, Choi SJ, Dai Ji J, Song GG.

Lupus. 2011 May;20(6):636-40. doi: 10.1177/0961203310389486. Epub 2011 Mar 7. Review.

PMID:
21382917
2.

The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.

Zhang X, Ji L, Yang L, Tang X, Qin W.

Int Urol Nephrol. 2016 May;48(5):731-43. doi: 10.1007/s11255-015-1201-z. Epub 2016 Jan 19. Review.

PMID:
26781720
3.

Tacrolimus use in lupus nephritis: A systematic review and meta-analysis.

Hannah J, Casian A, D'Cruz D.

Autoimmun Rev. 2016 Jan;15(1):93-101. doi: 10.1016/j.autrev.2015.09.006. Epub 2015 Sep 30. Review.

PMID:
26427983
4.

Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials.

Lee YH, Woo JH, Choi SJ, Ji JD, Bae SC, Song GG.

Scand J Rheumatol. 2010 Aug;39(4):271-8. doi: 10.3109/03009740903501642. Review.

PMID:
20476867
5.

Therapeutic options for resistant lupus nephritis.

Mok CC.

Semin Arthritis Rheum. 2006 Oct;36(2):71-81. Epub 2006 Jul 12. Review.

PMID:
16884971
6.

Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis.

Singh JA, Hossain A, Kotb A, Wells G.

BMC Med. 2016 Sep 13;14(1):137. doi: 10.1186/s12916-016-0673-8. Review.

7.

Treatment of lupus nephritis.

Dolff S, Berden JH, Bijl M.

Expert Rev Clin Immunol. 2010 Nov;6(6):901-11. doi: 10.1586/eci.10.79. Review.

PMID:
20979555
8.

Newer drugs for the treatment of lupus nephritis.

Kuiper-Geertsma DG, Derksen RH.

Drugs. 2003;63(2):167-80. Review.

PMID:
12515564
9.

Rituximab treatment in lupus nephritis--where do we stand?

Gunnarsson I, Jonsdottir T.

Lupus. 2013 Apr;22(4):381-9. doi: 10.1177/0961203312471574. Review.

PMID:
23553781
10.

Update on the treatment of lupus nephritis.

Hogan J, Appel GB.

Curr Opin Nephrol Hypertens. 2013 Mar;22(2):224-30. doi: 10.1097/MNH.0b013e32835d921c. Review.

PMID:
23328501
11.

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC.

Am J Kidney Dis. 2004 Feb;43(2):197-208. Review.

PMID:
14750085
12.

Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?

Boumpas DT, Sidiropoulos P, Bertsias G.

Nat Clin Pract Rheumatol. 2005 Nov;1(1):22-30. Review.

PMID:
16932624
13.

[Lupus nephritis].

Morović-Vergles J, Salamon L.

Reumatizam. 2009;56(2):34-40. Review. Croatian.

PMID:
20429260
14.

Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.

Chen SL, Yan J, Wang FS.

J Dermatolog Treat. 2010 May;21(3):144-56. doi: 10.3109/09546630903401470. Review.

PMID:
20394490
15.

Lupus nephritis: treatment of resistant disease.

Kalloo S, Aggarwal N, Mohan P, Radhakrishnan J.

Clin J Am Soc Nephrol. 2013 Jan;8(1):154-61. doi: 10.2215/CJN.05870612. Review.

16.

Epidemiology and management of refractory lupus nephritis.

Pons-Estel GJ, Serrano R, Plasín MA, Espinosa G, Cervera R.

Autoimmun Rev. 2011 Sep;10(11):655-63. doi: 10.1016/j.autrev.2011.04.032. Epub 2011 May 1. Review.

PMID:
21565286
17.

Overview of lupus nephritis management guidelines and perspective from Asia.

Mok CC, Yap DY, Navarra SV, Liu ZH, Zhao MH, Lu L, Takeuchi T, Avihingsanon Y, Yu XQ, Lapid EA, Lugue-Lizardo LR, Sumethkul V, Shen N, Chen SL, Chan TM; Asian Lupus Nephritis Network (ALNN).

Int J Rheum Dis. 2013 Dec;16(6):625-36. doi: 10.1111/1756-185X.12212. Epub 2013 Oct 31. Review.

PMID:
24382275
18.

Systematic review and meta-analysis of immunosuppressant therapy clinical trials in membranous lupus nephritis.

Swan JT, Riche DM, Riche KD, Majithia V.

J Investig Med. 2011 Feb;59(2):246-58. doi: 10.2310/JIM.0b013e318204c965. Review.

PMID:
21328792
19.

The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis.

Cao H, Rao Y, Liu L, Lin J, Yang H, Zhang X, Chen Z.

PLoS One. 2015 Dec 15;10(12):e0144548. doi: 10.1371/journal.pone.0144548. eCollection 2015. Review.

20.

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.

Weidenbusch M, Römmele C, Schröttle A, Anders HJ.

Nephrol Dial Transplant. 2013 Jan;28(1):106-11. doi: 10.1093/ndt/gfs285. Epub 2012 Jul 3. Review.

PMID:
22764193

Supplemental Content

Support Center